A carregar...

Cyclin-dependent kinase 7 inhibitor THZ1 in cancer therapy

Current cancer therapies have encountered adverse response due to poor therapeutic efficiency, severe side effects and acquired resistance to multiple drugs. Thus, there are urgent needs for finding new cancer-targeted pharmacological strategies. In this review, we summarized the current understandi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Chronic Dis Transl Med
Main Authors: Li, Bin-Bin, Wang, Bo, Zhu, Cheng-Ming, Tang, Di, Pang, Jun, Zhao, Jing, Sun, Chun-Hui, Qiu, Miao-Juan, Qian, Zhi-Rong
Formato: Artigo
Idioma:Inglês
Publicado em: Chinese Medical Association 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6926117/
https://ncbi.nlm.nih.gov/pubmed/31891127
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cdtm.2019.08.006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!